Screener
Gyre Therapeutics, Inc. GYRE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Other receivables from GNI | 255 | 230 |
| Inventories, net | 11,428 | 10,171 |
| Prepaid assets and other current assets | 7,601 | 9,613 |
| Total current assets | 122,072 | 149,362 |
| Property and equipment, net | 27,284 | 27,549 |
| Intangible assets, net | 4,525 | 4,727 |
| Long-term prepayments | 302 | 112 |
| Deferred tax assets | 9,284 | 6,873 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s total current assets?
- Gyre Therapeutics, Inc. (GYRE) reported total current assets of $122.07M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s total current assets changed year-over-year?
- Gyre Therapeutics, Inc.'s total current assets increased by 33.7% year-over-year, from $91.29M to $122.07M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s total current assets has grown at a 10.8% compound annual growth rate (CAGR), from $89.51M to $149.36M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Gyre Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude